Comparison of different methods for detecting epidermal growth factor receptor mutations in peripheral blood and tumor tissue of non-small cell lung cancer as a predictor of response to gefitinib - Wikidata - wikimedia - TriplyDB

Comparison of different methods for detecting epidermal growth factor receptor mutations in peripheral blood and tumor tissue of non-small cell lung cancer as a predictor of response to gefitinib

Comparison of different methods for detecting epidermal growth factor receptor mutations in peripheral blood and tumor tissue of non-small cell lung cancer as a predictor of response to gefitinib

http://www.wikidata.org/entity/Q36474664

about

Circulating DNA in diagnosis and monitoring EGFR gene mutations in advanced non-small cell lung cancer Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancer Emerging platforms using liquid biopsy to detect EGFR mutations in lung cancer Blood as a Substitute for Tumor Tissue in Detecting EGFR Mutations for Guiding EGFR TKIs Treatment of Nonsmall Cell Lung Cancer: A Systematic Review and Meta-Analysis Liquid biopsy genotyping in lung cancer: ready for clinical utility?Cross-Platform Comparison of Four Leading Technologies for Detecting EGFR Mutations in Circulating Tumor DNA from Non-Small Cell Lung Carcinoma Patient Plasma Prognostic value of EGFR and KRAS in circulating tumor DNA in patients with advanced non-small cell lung cancer: a systematic review and meta-analysis.Peripheral blood for epidermal growth factor receptor mutation detection in non-small cell lung cancer patients.Serum proteomic study on EGFR-TKIs target treatment for patients with NSCLC.Detection of epidermal growth factor receptor mutation in lung cancer by droplet digital polymerase chain reaction.The Emergent Landscape of Detecting EGFR Mutations Using Circulating Tumor DNA in Lung Cancer.EGFR mutation testing in blood for guiding EGFR tyrosine kinase inhibitor treatment in patients with nonsmall cell lung cancer: A protocol for systematic review and meta-analysis Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma.Clinical Utility of Liquid Diagnostic Platforms in Non-Small Cell Lung Cancer.Circulating cell-free DNA has a high degree of specificity to detect exon 19 deletions and the single-point substitution mutation L858R in non-small cell lung cancer.Can peripheral blood be used as surrogate in detecting epidermal growth factor receptor mutation status in advanced non-small cell lung cancer patients? A meta-analysis.Comparison of cross-platform technologies for EGFR T790M testing in patients with non-small cell lung cancer.Incorporating Blood-based Liquid Biopsy Information into Cancer Staging: Time for a TNMB System?Molecular characteristics and clinical outcomes of EGFR exon 19 indel subtypes to EGFR TKIs in NSCLC patients.Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer.Circulating tumour DNA in EGFR-mutant non-small-cell lung cancer.Liquid Biopsy as Surrogate to Tissue in Lung Cancer for Molecular Profiling: A Meta-Analysis

P2860

Q26775376-9D5DAD5D-B84E-4411-B2A3-82FFC4BCBF70 Q26801357-C24F9982-D89D-44D6-90BD-13D70124B2AC Q28082499-7F5E7C36-9AAE-457C-8481-784ACA2891B0 Q28087366-851561C7-2389-4610-BAAF-7DE0501A8B7D Q33567037-6C5375A7-1319-410C-A393-6165801678E0 Q33703063-F0CA7C0F-EE1B-4F8D-841C-6C1FDD844182 Q33779727-7C5D7D0F-A496-4BB4-9607-7D161E3C7000 Q34092157-34C2715F-2C5F-436E-A120-AE7AA12EBAF5 Q35034044-68691DC6-FE07-466A-9746-17C629551D77 Q35787132-C0F74C96-9042-45DE-AC42-08448C58732D Q36095650-0AADD218-0045-44E5-9724-585E62094FFC Q36282366-7DACDA81-80B3-4EAC-91BA-A6A615F2EE00 Q37743832-C2CCB1B0-28F3-4291-B8B9-73603632DDD0 Q38694431-4609150F-F135-4CB7-BA86-B04698CC7331 Q38844281-90E9F91A-44BA-40D9-9755-22FACB4BDCF5 Q41260159-CACB8042-50D9-4BF9-AB50-421337907E15 Q43172646-21C5EB41-8C22-4CB4-8D38-C9910A9175D5 Q47162466-80498AB6-21E8-4242-A2C8-9D81D27CA0DC Q47563363-516418D1-FB27-41C5-9229-DE853150B943 Q49450097-2067DF61-1D0F-4430-A234-691AA5D9DB68 Q49887989-8AD2D157-05C0-49E9-8EDC-6249799EAD20 Q55282794-8648C432-6E7E-4C78-8CD2-0057CAF890A8 Q57147737-58D7AFD4-F85D-4AB3-A9B3-C0D3EB055AEB

P2860

Comparison of different methods for detecting epidermal growth factor receptor mutations in peripheral blood and tumor tissue of non-small cell lung cancer as a predictor of response to gefitinib

http://www.wikidata.org/entity/Q36474664

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Comparison of different method ...... ictor of response to gefitinib

@ast

Comparison of different method ...... ictor of response to gefitinib

@en

type

label

Comparison of different method ...... ictor of response to gefitinib

@ast

Comparison of different method ...... ictor of response to gefitinib

@en

prefLabel

Comparison of different method ...... ictor of response to gefitinib

@ast

Comparison of different method ...... ictor of response to gefitinib

@en

P1433

Q36474664-BC0DC226-9258-450C-BC30-D0223CCAE084

P1476

Q36474664-1F0FC49C-7DAC-4C14-A977-F77A75B16D9A

P2093

Q36474664-14006265-3472-4861-8D01-C5006A616D01

Q36474664-1BAF9240-5B79-48E8-801F-D72FF8D59A39

Q36474664-26E16C9C-D106-4750-8D5B-3556AAD37A81

Q36474664-336ADB5A-FDCF-4C45-A2FF-7D60CE50F90A

Q36474664-61D94FA7-828F-4544-A255-458FF30992AF

Q36474664-6B17B4BB-8C75-4594-A90C-53E8D5B3CFEE

Q36474664-6E9450B0-DBB1-4B22-A2C9-0E58F21D8124

Q36474664-7403C174-9432-4A1B-AE84-9310CF86F04E

Q36474664-9FAC2CC3-29C8-4A7B-9652-9B23174790F7

Q36474664-A45996EB-81A8-4722-9D57-2C9815428416

P2860

Q36474664-1C5C6D31-85E6-49AD-8AD2-9598EE2AF0D5

Q36474664-1F89428B-1ABA-47DA-921E-0D06A8AFDDF6

Q36474664-2F9D0B6B-F1E3-4614-8789-B97802263659

Q36474664-2FC28608-95F0-472F-9DA8-304035B3E4F6

Q36474664-339B5F96-D9E8-4E2B-90F9-008F1B56F3B4

Q36474664-37CC792B-D6C7-4555-9E7F-49FD58C89A97

Q36474664-39E36FC0-E4DC-4599-8A90-A0EDCFAD219D

Q36474664-3A53B7B3-AD79-4D53-BB15-03699C7788B9

Q36474664-3AB743A7-F6B2-4BA3-BBDA-3DD6CB889DC2

Q36474664-47F7D14C-291B-48CF-B3DD-46203F92C874

P304

Q36474664-888D8827-BB54-42A1-AFC2-EED3D24CBCE8

P31

Q36474664-BBB7BEC9-B5C9-45E3-B341-5F2B97A1D148

P356

Q36474664-CFC38B0D-A43B-4F11-89E3-A874FC2F398B

P407

Q36474664-B430B186-31BA-4904-9E7F-BE1753849136

P478

Q36474664-44C37F58-F56A-4917-9BD7-8DC87CFD3E46

P577

Q36474664-C4426502-F2E9-4755-97D1-70AFCF4463B6

P698

Q36474664-158C5862-275E-4CEF-8769-AFD6F712480E

P932

Q36474664-EAFC5E76-6489-4E05-B94F-4FCC2CB3C1DA

P356

P1433

OncoTargets and Therapy

P1476

Comparison of different method ...... ictor of response to gefitinib

@en

P2093

Cong Xue

http://www.w3.org/2001/XMLSchema#string

Fei Xu

http://www.w3.org/2001/XMLSchema#string

Guanshan Zhu

http://www.w3.org/2001/XMLSchema#string

Hua Bai

http://www.w3.org/2001/XMLSchema#string

Jiasen Xu

http://www.w3.org/2001/XMLSchema#string

Jingxun Wu

http://www.w3.org/2001/XMLSchema#string

Li Zhang

http://www.w3.org/2001/XMLSchema#string

Liping Lin

http://www.w3.org/2001/XMLSchema#string

Wei Jiang

http://www.w3.org/2001/XMLSchema#string

Xuan Wu

http://www.w3.org/2001/XMLSchema#string

P2860

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Epidermal growth factor-related peptides and their receptors in human malignancies

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

Erlotinib in previously treated non-small-cell lung cancer

Detection of mutations in EGFR in circulating lung-cancer cells

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

P304

439-447

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S37289

http://www.w3.org/2001/XMLSchema#string

P407

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23251095

http://www.w3.org/2001/XMLSchema#string

P932

3525047

http://www.w3.org/2001/XMLSchema#string